Covid-19 Research

Article Figures

Evaluation of the Effect of Ligaria cuneifolia Infusion on Plasma Cholesterol and Liver and Kidney Function in Patients with Cardiovascular Risk

View article figures, article metadata, topics, DOI, abstract, and related articles from the JBRES article record.

View Abstract Article Library
Article Type: Original Article Published: 2025-07-09 Volume/Issue: 6 / 7 Pages: 862-867

Evaluation of the Effect of Ligaria cuneifolia Infusion on Plasma Cholesterol and Liver and Kidney Function in Patients with Cardiovascular Risk

Francisco Pons, Martin Perez, Mariana Ferrero, Leda Urli, Josu00e9 Gonzalvez, Juan Alonso, Daniel De Vuono, Cecilia Dobrecky, Rodolfo Leiva, Marcelo Wagner, Cristina Carnovale and Alejandra Luquita
Abstract PDF DOI
Liver Pharmacology Public Health Cardiovascular Diseases
Evaluation of the Effect of Ligaria cuneifolia Infusion on Plasma Cholesterol and Liver and Kidney Function in Patients with Cardiovascular Risk
jbres2139-g001.webp

Article Figures

Abstract

<p>Ligaria cuneifolia (R. et P.) Tiegh. –Loranthaceae– (Lc), commonly used in traditional medicine, is believed to reduce total plasma cholesterol (TC) and improve blood flow.</p><p>&nbsp; <br>Objective: To evaluate the effect of ingesting Lc infusions on plasma cholesterol, Whole Blood Viscosity (WBV), Hepatic Function (HF), and Renal Function (RF) in patients with cholesterol levels &gt;200 mg/dL.</p><p>&nbsp; <br>Methods: Twelve patients were studied. Baseline venous Blood samples (B) were collected for initial measurements. Each participant received freeze-dried Lc extract to be ingested as an infusion three times per week. After 31 days, post-treatment blood samples (TLc) were obtained. Plasma determinations included: TC, High-Density Lipoprotein Cholesterol (HDL-C), Low-Density Lipoprotein Cholesterol (LDL-C), urea, and creatinine using enzymatic methods (mg/dL); Alkaline Phosphatase (ALP), Alanine Aminotransferase (ALT), and Aspartate Aminotransferase (AST) using kinetic methods (U/L); and WBV using a rotational viscometer. Relative Blood Viscosity (RBV) was calculated.</p><p>&nbsp; <br>Statistical analysis<br>Wilcoxon test for paired data. Results (median and 95% CI): TC: B: 230 (205-278); TLc: 229.6 (200-251) ns; HDL-C: B: 59 (42-84); TLc: 63.5 (35-76) ns; LDL-C: B: 185.5 (140-239); TLc: 169.5 (135-215) *; RBV: B: 2.99 (2.5-3.38); TLc: 3.05 (2.20-3.79) ns; AST: B: 21.5 (15-30); TLc: 20.5 (15-32) ns; ALT: B: 21 (6-31);TLc: 17.5 (7-27) *; ALP: B: 77 (55-100); TLc: 77 (70-100) ns; urea: B: 31.5 (22-52); TLc: 33 (22-49) ns; creatinine: B: 0.89 (0.711.22); TLc: 0.83 (0.580.13) ns. (*p &lt; 0.05 vs B; ns = n significant vs B). Conclusion: The treatment significantly reduced LDL-C levels without altering TC, HDL-C, RBV, RF, AST, or ALP. ALT, a biochemical marker of hepatic steatosis, was also significantly reduced. Given the association between LDL-C and atherosclerosis, these findings suggest Lc could be a viable option for cardiovascular disease prevention.<br></p>

Similar Topic Articles

  • Hepatoid Adenocarcinoma of the Stomach with Liver and Pulmonary Metastases: A Case Report and Literature Review
    Guangyong Peng, Zhiwu Zeng, Yinbiao Qiao, Wengui Ma, Kun Zhao, Xiaoting Zhang, Xu Zhang*, Jianhui Li* and Yaxian Mo*
    Published: 2024-03-23
    Abstract FullText HTML PDF DOI
  • Induction Therapy with Bortezomib Cyclophosphamide Dexamethasone and Conditioning with Lenalidomide for Al Renal Amyloidosis: Long-Term Follow Up
    Greco Rosita*, Agata Mollica, Botta Cirino, Gentile Massimo, Enrica Martino and Papalia Teresa
    Published: 2024-02-28
    Abstract FullText HTML PDF DOI
  • Morphometric Analysis of Common Bile Duct: A Cadaveric Study
    Sanjay Kumar Sah*, Himal Panth and Ying Xiong Wang
    Published: 2021-02-23
    Abstract FullText HTML PDF DOI
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership